Myocyte enhancer factor 2 C (MEF2C) is an important transcription factor during 21 neurodevelopment. Mutation or deletion of MEF2C causes intellectual disability (ID) and common
variants within MEF2C are associated with cognitive function and schizophrenia risk. We investigated 23 if genes influenced by MEF2C during neurodevelopment are enriched for genes associated with 24 neurodevelopmental phenotypes, and if this can be leveraged to identify biological mechanisms and 25 individual brain cell types affected. We used a set of 1,052 genes that were differentially expressed 26 in the adult mouse brain following early embryonic deletion of Mef2c in excitatory cortical neurons.
27
Using GWAS data, we found these differentially expressed genes (DEGs) to be enriched for genes 28 associated with schizophrenia, intelligence and educational attainment but not autism spectrum 29 disorder (ASD). Using sequencing data from trios studies, we found these DEGs to be enriched for 30 genes containing de novo mutations reported in ASD and ID, but not schizophrenia. Using single cell 31 RNA-seq data, we identified that a number of different excitatory glutamatergic neurons in the 32 cortex were enriched for these DEGs including deep layer pyramidal cells and cells in the 33 retrosplenial cortex, entorhinal cortex and subiculum. These data indicate that genes influenced by 34 MEF2C during neurodevelopment contribute to cognitive function and risk of neurodevelopmental 35 disorders. Within excitatory neurons, common SNPs in these genes contribute to cognition and SZ 36 risk via an effect on synaptic function based on gene ontology analysis. In contrast, rare mutations 37 contribute to earlier onset ASD and ID via an effect on cell morphogenesis.
40
Author Summary 41 Schizophrenia is a complex disorder caused by many genes. Current drugs for schizophrenia are only 42 partially effective and do not treat cognitive deficits, which are key factors for explaining disability.
43
Here we take an individual gene identified in genetic studies of schizophrenia and cognition called 44 MEF2C, which on its own is a very important regulator of brain development. We use data from a 45 mouse study where MEF2C has been stopped from functioning or knocked out during brain 46 development. The effect of that knock out has been measured when the mice reach adulthood, in 47 the form of a set of differentially expressed genes (DEGs) from the somatosensory cortex. We found 48 that this set of DEGs contains more genes than expected by chance that are associated with 49 schizophrenia and cognition or contain rare new (de novo) mutations reported in autism and 50 intellectual disability. Using gene expression data from single brain cells, we identified that a number 51 of specific excitatory glutamatergic neurons in the cortex were enriched for these DEGs. would also be associated with these phenotypes. We investigated this using the set of DEGs 121 reported by Harrington et al. (13) . We tested and found that the DEGs are enriched for genes 122 associated with IQ, EA and SZ using gene-set analysis of GWAS data and are enriched for genes 123 containing de novo mutations reported in exome sequencing studies of ASD and ID trios. To gain 124 further biological insights, we then leveraged these contributions of the MEF2C-influenced genes to 125 neurodevelopment to investigate which individual cell types are enriched for these genes using 126 single cell RNA-seq (scRNA-seq) data from the mouse brain and performed gene ontology analysis to 127 help identify the molecular mechanisms involved.
129

Results
130
Comparison of association signals at MEF2C in GWAS data
131
We reviewed the largest published GWAS, which report that SNPs at the MEF2C locus are genome-132 wide significant for SZ, IQ and EA but not ASD (S1 Figure A- 
Analysis of MEF2C cKO gene-set in GWAS data
150
We used a set of 1,055 DEGs (listed in S1 Table) based on an RNA-seq study that captured the 151 transcriptional changes in adult male mouse brain that result from the early embryonic deletion of 152 Mef2c in cortical and hippocampal excitatory neurons (13). RNA-seq was performed on mRNA 153 isolated from the somatosensory cortex of Mef2c cKO or control littermates (13). These genes that 154 were differentially expressed upon cKO of MEF2C were enriched for genes associated with SZ 155 (P=1.70x10 -06 ), IQ (P =9.88x10 -08 ) and EA (P=2.24x10 -10 ) but not ASD (P=0.247; see Table 1 ). Brain-156 expressed genes are a major contributor to these phenotypes. It is possible that the enrichment 157 detected here could be due to the MEF2C gene-set representing a set of brain-expressed genes.
158
However, the MEF2C enrichment was robust to the inclusion in the analyses of both 'brain-159 expressed' (n=14,243) and 'brain-elevated' (n=1,424) gene-sets as covariates (S2 Table) . To examine 160 if the enrichment we detect for SZ, IQ and EA is a property of polygenic phenotypes in general, we 161 obtained GWAS summary statistics for ten phenotypes and tested the MEF2C gene-set for 162 enrichment in each one. These were a child-onset psychiatric disorders, other brain-related 163 disorders, non-brain related diseases, and height. No enrichment was detected for any of the ten 164 phenotypes (S3 Table) .
165 Cell type enrichment analysis
210
By performing enrichment analysis on gene expression data from scRNA-seq of the mouse nervous 211 system, we sought to detect individual cell types that are enriched for genes that are differentially 212 expressed upon cKO of MEF2C. We used two scRNA-seq data-sets that included 265 cell types from 213 the mouse nervous system (28) and 565 cell types from the mouse brain (29). After Bonferroni 214 correcting for the 830 cell types tested, we identified 31 significantly enriched cell types in both 215 data-sets (62 cell types in total with p<6.03x10 -5 ). These results are summarized in Table 4 and full   216 details are provided in S9-10 Tables. Mef2c in the animal model, the majority of cell types affected are glutamatergic excitatory neurons.
217
280
The advantage of these large scRNA-seq resources is that we can identify some of the specific 281 regions and cell types affected. A number of the regional locations were identified in both analyses 282 of scRNA-seq data and have previously been implicated in neurodevelopmental disorders.
283
Transcriptomic analysis of dorsolateral prefrontal cortex layer 3 and layer 5 pyramidal cells have 284 identified changes in gene expression between SZ cases and controls (31). LoF mutations in 285 transcription factor T-brain-1 (TBR1) have been reported in ASD patients and conditional Tbr1 286 deletion during late mouse gestation in cortical layer 6 neurons affects processes such as dendritic 287 patterning and synaptogenesis (32). The retrosplenial cortex, a sub-region of the cingulate cortex, 288 exhibited impaired function using a semantic memory task (33) and showed reduced grey matter 289 volumes (34) in SZ patients. The common set of brain regions that underlies the default mode 290 network, autobiographical memory, prospection, navigation, and theory of mind may include the 291 retrosplenial cortex (35). Resting state connectivity of the retrosplenial cortex is altered in SZ 292 patients, with connectivity differences observed to brain areas associated with language processing, 293 suggesting a role for the retrosplenial cortex in the aetiology of hallucinations (36). In ASD, resting 294 state overconnectivity between the anterior insula and the retrosplenial cortex is associated with 295 internalizing symptoms (anxiety, depression, social withdrawal) (37)). 
